This inventor holds 4 USPTO granted patents and 12 published patent applications. Top assignee: Integrated Dna Technologies, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovative Contributions of Sarah Franz Beaudoin
Introduction
Sarah Franz Beaudoin is a prominent inventor based in Iowa City, IA (US). She has made significant contributions to the field of biotechnology, particularly in the development of novel enzymes and nucleic acids. With a total of 4 patents, her work has advanced the understanding and application of reverse transcriptase and CRISPR technology.
Latest Patents
One of her latest patents is titled "Reverse transcriptase mutants with increased activity and thermostability." This invention provides mutants of Moloney murine leukemia virus (MMLV) reverse transcriptase (RTase) that exhibit enhanced performance. The patent outlines suitable amino acid positions in MMLV RTase for mutagenesis, along with methods and kits for utilizing these mutants to synthesize cDNA from RNA templates.
Another significant patent is "ND2006 CAS12A mutant genes and polypeptides encoded by same." This invention focuses on mutant ND2006 (Lb) Cas12a nucleic acids and proteins designed for use in CRISPR/Cas12a endonuclease systems. It includes an isolated mutant LbCas12a protein that is active in these systems, as well as isolated nucleic acids encoding these proteins and related ribonucleoprotein complexes.
Career Highlights
Sarah is currently employed at Integrated DNA Technologies, Inc., where she continues to innovate and contribute to the field of genetic engineering. Her work has not only advanced scientific knowledge but has also paved the way for practical applications in various biotechnological fields.
Collaborations
Throughout her career, Sarah has collaborated with notable colleagues, including Christopher Anthony Vakulskas and Michael Allen Collingwood. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
In summary, Sarah Franz Beaudoin is a trailblazer in the field of biotechnology, with a focus on reverse transcriptase and CRISPR technology. Her innovative patents and contributions to Integrated DNA Technologies, Inc. highlight her significant impact on the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile